News
June 2, 2009 - Cordex Pharma Inc. said today the FDA cleared the design of pivotal, phase 2b/3 clinical trials evaluating its lead product ATPace as an antiarrhytmic drug for the acute treatment of patients with paroxysmal supraventricular tachycardia (PSVT) under the special protocol assessment (SPA) process.
June 02, 2009
News
June 1, 2009 - Devax Inc. today said FDA has conditionally approved an investigational device exemption (IDE) for its AXXESS Biolimus A9-Eluting Bifurcation Stent System, allowing the company to initiate a pivotal clinical trial (DIVERGE II) of the device in the U.S.
June 01, 2009
News
June 1, 2009 - Six months after placement of a vProtect Luminal Shield to treat a "vulnerable plaque,” a follow-up exam revealed reduced plaque burden and reduced stenosis in the target vessel.
June 01, 2009Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
June 1, 2009 - A new study shows about 2 percent of 18,165 patients undergoing cardiac catheterization had femoral vascular complications. The study conducted by the Bad Berka Central Clinic, Department of Cardiology in Germany, appears in the June 12 issue of the International Journal of Cardiology (Volume 135, June 12, 2009, Issue 1, Pages 66-71).
June 01, 2009
Feature
June 1, 2009 - Results and updates from eight studies were presented during a late-breaking trials session at Heart Failure 2009, May 30 – June 2 in Nice, France. Professor John McMurray, president of the Heart Failure Association, described the trials’ objectives and main implications.
June 01, 2009
Technology
May 29, 2009 - Saint Francis Hospital in Evanston, Ill. has become the first hospital in Illinois to offer the new PRIME ECG made by Heartscape Technologies, which has a disposable vest containing 80 electrocardiogram leads that detect heart rhythm and blockages in 360-degrees of the heart.
May 29, 2009Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
May 29, 2009 - Celladon Corp. this week presented phase 1 data from the Calcium Up-Regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID), a first-in-human phase 1/2 clinical trial, in a scientific symposium at the 12th Annual American Society of Gene Therapy Meeting.
May 29, 2009
News
May 28, 2009 - Lantheus Medical Imaging Inc. has completed patient enrollment of CaRES (Contrast Echocardiography REgistry for Safety Surveillance), the first, multicenter Phase IV observational registry that evaluates the use of ultrasound imaging agents in routine clinical practice. The 1,060 patients who were enrolled at 15 sites in the U.S.
May 28, 2009
Technology
The Simbionix ANGIO Mentor family of cath lab simulators provide hands-on practice for multiple disciplines in an extensive and complete simulated environment of interventional endovascular procedures. Interventional cardiologists, interventional radiologists and vascular surgeons can use it to perform complete procedures, as well as acquiring basic skills.
May 28, 2009Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
Technology
May 28, 2009 - Boston Scientific Corp. said yesterday it received FDA clearance to market its TAXUS Liberte Atom Paclitaxel-Eluting Coronary Stent System, a next-generation drug-eluting stent (DES) specifically designed for treating small coronary vessels.
May 28, 2009News
May 28, 2009 – Lantheus Medical Imaging Inc. today said it completed patient enrollment of CaRES (Contrast Echocardiography REgistry for Safety Surveillance), the first, multicenter phase IV observational registry that evaluates the use of ultrasound imaging agents in routine clinical practice.
May 28, 2009News
May 26, 2009 – HeartCare Cardiovascular Specialists in Libertyville, Ill. expanded its CVIS capabilities with a new DigiNet Pro system. This system will provide the site with Web access enabling users to have full CVIS capability from anywhere at anytime.
May 28, 2009Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Technology
May 26, 2009 - ProSolv Cardiovascular, a Fujifilm company, this week released its Synapse ProSolv Cardiovascular version 4.0.2 software.
May 27, 2009News
May 27, 2009 - Cytori completed enrollment in the first study to investigate adipose derived stem and regenerative cells in chronic heart disease.
May 27, 2009News
May 26, 2009 – The Medical Imaging and Technology Alliance said today a recent study conducted by researchers at the University of Pennsylvania confirms computed tomography angiography (CTA) to be a safe, effective and cost-efficient means of ruling out cardiovascular disease in patients presenting to the emergency room with chest pain. The results of this landmark study were presented at the
May 26, 2009© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now